A federal jury has ordered medical device manufacturer C.R. Bard to pay $3.6 million to a Georgia woman who was injured by a faulty Inferior Vena Cava (IVC) filter.
A Chicago jury this week ordered Illinois drug maker AbbVie to pay more than $3 million in damages to a man who suffered a heart attack after years of using its testosterone replacement therapy drug AndroGel.
11 year-old Hadley Lucca’s goals for each day sound simple. Like many other girls her age, she wants to bake cookies, put on earrings and tie her hair in ponytails.
The U.S. Food and Drug Administration has identified a troubling number of reports of both pancreatitis and liver damage among patients taking the popular rheumatoid arthritis drug Actemra.
It’s been a mere five years since Johnson & Johnson launched their blockbuster diabetes drug Invokana. In that time, it has climbed into the top-ten most prescribed medications for diabetes, with billions of dollars in sales.
On February 1st, a Kentucky man filed the latest DePuy Attune knee lawsuit against Warsaw, Indiana-based DePuy Orthopedics, alleging that defective design of their Attune knee implants led to tibial loosening (link to Attune loosening page) and device failure.
Last week, Indianapolis-based drug maker Eli Lilly announced data from a study showing that, by combining the two different types of diabetes drugs, Jardiance and Trulicity, more patients may be able to reach target blood sugar levels than by using one drug alone.
A federal appeals court recently signed an order resurrecting around 750 lawsuits filed against the makers of drugs like Januvia, Victoza, Janumet, Byetta/Bydureon, Trulicity and Tradjenta over links to pancreatic cancer.